Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03022565
Title Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nicolas Acquavella
Indications

uveal melanoma

Therapies

Vorinostat

Age Groups: adult | senior
Covered Countries


No variant requirements are available.